EMA Allows Labeling Flexibilities for COVID-19 Therapeutics

March 18, 2021

The European Medicines Agency (EMA), which eased certain labeling requirements for COVID-19 vaccines in December, now says some of the same product labeling flexibilities may apply to COVID-19 therapeutics.

The agency said COVID-19 therapeutics can use English-language-only packaging in member states if the products meet certain criteria, such as being a prescription-only drug that is also a candidate for conditional marketing authorization.

The eased labeling requirements are “reserved for medicines with an important role in tackling the pandemic,” including products under rolling review, EMA said.

View today's stories